2020
DOI: 10.1016/j.lfs.2020.118302
|View full text |Cite
|
Sign up to set email alerts
|

Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 50 publications
0
5
0
Order By: Relevance
“…Although ERα and ERβ were well-characterized ER isoforms, the results in literature findings of their expression on pancreatic cancer cell lines were conflicting [ 25 , 26 , 27 ]. According to our experimental results, all three cell lines expressed the ERα to a varying degree in nuclear localization ( Figure 7 A–C).…”
Section: Resultsmentioning
confidence: 99%
“…Although ERα and ERβ were well-characterized ER isoforms, the results in literature findings of their expression on pancreatic cancer cell lines were conflicting [ 25 , 26 , 27 ]. According to our experimental results, all three cell lines expressed the ERα to a varying degree in nuclear localization ( Figure 7 A–C).…”
Section: Resultsmentioning
confidence: 99%
“…ERbeta/ERalpha ratio may even affect the estrogen-mediated growth stimulation and then reduce cytotoxicity at physiological concentrations that may possess some clinical implications for pancreatic cancer therapy [ 40 ]. A recent study demonstrated the critical roles of estrogen receptors and the efficacies of anti-estrogen therapy in both pancreatic cancer cell’s proliferation as well as cancer progression’s inhibition [ 41 ]. In some previous studies, it was suggested that T-box factors, especially Tbx2, as transcription factors, play important roles in controlling cell cycle progression, embryonic development, and cancer genesis.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, the AMRs of ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers increased significantly beyond the predicted rates, especially in 2022. All of these cancers are known as estrogen and estrogen receptor alpha (ERα)-sensitive cancers [78][79][80][81][82][83]. Recent research by Solis et al on the binding ability of S-protein of SARS-CoV-2 against over 9,000 human proteins has shown that S-protein specifically binds to ERα and upregulates the transcriptional activity of ERα.…”
Section: Cancer Development By Sars-cov-2 Mrna Vaccinementioning
confidence: 99%